Welcome to our dedicated page for ADM TRONICS UNLTD news (Ticker: ADMT), a resource for investors and traders seeking the latest updates and insights on ADM TRONICS UNLTD stock.
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) specializes in the design, development, and manufacturing of electronic medical devices for diagnostic and therapeutic applications at its FDA-registered facility. ADMT stands out as a one-stop source offering complete services including design, engineering, regulatory, and manufacturing, enabling seamless transition from concept to production. This integrated approach sets ADMT apart from firms that provide only partial services.
ADMT's expertise encompasses a range of proprietary medical devices in various fields such as audiology, physical medicine, wound therapy, neurology, and urology. Their notable projects include the development of the Vet-Sonotron®, a non-invasive pain treatment device for veterinary applications, and the ongoing work towards launching a human version. The Vet-Sonotron has shown remarkable efficacy in treating musculoskeletal pain without the need for drugs, signaling a significant advancement in veterinary and potentially human medicine.
Financially, ADMT has demonstrated robust growth with significant increases in net income and revenue across its operating segments which include Electronics, Engineering, and Chemical. For the nine months ended December 31, 2022, ADMT reported net income of $155,148, reversing a net loss of $140,221 from the previous year, driven by a 31% increase in revenues. They continued this positive trend into fiscal 2023 with a sustained increase in revenue and profit despite challenges in raw material supply.
ADMT's commitment to innovation is evidenced by its ongoing investment in research and development. The company recently expanded its capabilities with the introduction of the IonoJet™ by Origin Life Sciences, a plasma-generated nitric oxide device, developed in partnership with ADMT. This device aims to address fungal infections and chronic wounds, showcasing ADMT's versatility and expertise in medical technology development.
Headquartered in Northvale, NJ, ADMT operates with a multidisciplinary team of engineers, researchers, and technologists, utilizing state-of-the-art infrastructure. Their comprehensive approach ensures the delivery of effective and innovative medical solutions. For more information, visit admtronics.com.
ADM Tronics Unlimited (ADMT) has signed a five-year marketing and distribution agreement with SBLP Capital for its Vet-Sonotron veterinary therapy device. This device targets equine and small animal markets in key countries, including the U.S., Canada, and several European nations. The agreement, which can be renewed for another five years, is based on minimum sales requirements. Positive feedback on pre-production units suggests strong market potential. The Vet-Sonotron treats musculoskeletal pain using pulsed radio frequency therapy, enhancing ADMT's product portfolio.
ADM Tronics Unlimited, Inc. (OTCQB - ADMT) has announced the completion of its new Vet-Sonotron® device, designed for treating musculoskeletal pain and inflammation in animals. The device utilizes pulsed radio frequency therapy (PRFT) and is aimed at small and large animals, including thoroughbreds and dressage horses. Following pre-production evaluations, the company plans to commercialize the Vet-Sonotron, anticipating significant benefits in animal therapy. Additionally, the company provides manufacturing and regulatory services at its FDA-registered facility in Northvale, NJ.
ADM Tronics Unlimited, Inc. (OTCQB - ADMT) won First Place in Electronics at the Go Global Awards on October 14, 2021. This accolade recognizes the company’s innovation and leadership in electronic medical device development. Competing against 6,416 entries from 178 countries, ADMT's President, Andre DiMino, expressed gratitude for the honor, emphasizing the company’s commitment to quality in electronic technologies. The Go Global Awards celebrate organizations that contribute to the global economy through innovative strategies.
ADM Tronics Unlimited (OTCQB - ADMT) has been selected by Intubation Science, Inc. to finalize the engineering and manufacturing of the Light Speed Intubator-Imaging Stylet System. This innovative, single-use intubation device aims to enhance airway visualization and improve patient safety during intubation procedures.
The system is designed for hospital use and emergency responders, particularly during the COVID-19 pandemic. ADMT will also ensure regulatory compliance for volume production at its FDA-Registered facility in Northvale, NJ.
ADM Tronics Unlimited (OTCQB:ADMT) reported improved financial results for the first fiscal quarter ended June 30, 2021. Revenues rose by over 26% to $721,358 compared to $569,093 in the previous year, attributed to customer activity resuming post-COVID-19 disruptions. Engineering services saw revenue growth of 94% to $183,527, while the chemical segment grew 69% to $315,257. However, the electronics manufacturing segment faced a 23% decline due to raw material shortages. Net loss decreased by 73% to $30,672 from $115,736 in Q1 2020.
ADM Tronics Unlimited, Inc. (OTCQB:ADMT) reported its fiscal year results for the year ending March 31, 2021, highlighting the impact of the COVID-19 pandemic on operations. The company experienced an 11% decline in revenues, totaling $3,090,631, compared to $3,485,992 the previous year. Operating expenses rose to $1,842,320 from $1,617,409. Loss from operations was $680,478, increasing from $43,389. Despite challenges, ADMT increased its R&D investments and is exploring partnerships for future commercialization of its medical device technologies.
ADM Tronics Unlimited, Inc. (ADMT) announced its participation in the Lytham Partners Summer 2021 Investor Conference, scheduled from June 14 to June 16, 2021. President Andre DiMino will be available for virtual one-on-one meetings during the event, where he aims to discuss the company's activities and developments. ADMT specializes in designing, developing, and manufacturing electronic medical devices at its FDA-Registered and ISO-Certified facility in Northvale, NJ, with a unique capability to handle all phases of medical device development in-house.
ADM Tronics Unlimited, Inc. (ADMT) has partnered with Ventis Medical, Inc. to manufacture and support the regulatory compliance for their Ventis VM-2000 Ventilator, designed for emergency use. This ventilator aims to provide a low-cost and user-friendly solution for critical healthcare needs, addressing situations where traditional ventilators are unavailable. ADMT will utilize its FDA-Registered facility in New Jersey for the manufacturing process, actively working with VMI to meet necessary regulatory requirements for both US and international distribution.
ADM Tronics Unlimited (ADMT) has secured the Infectious Disease Prevention Training Certification from the NJBIA, establishing a comprehensive disease prevention plan that aligns with WHO and CDC guidelines. This certification emphasizes ADMT's commitment to employee and community health amidst the COVID-19 pandemic while maintaining operational continuity. The company continues its focus on developing medical technologies at its FDA-Registered facility in Northvale, NJ. ADMT specializes in electronic medical devices and offers complete design and manufacturing services.
ADM Tronics Unlimited, Inc. (ADMT) reported a 5% decrease in revenues for the third fiscal quarter ended December 31, 2020, totaling $762,644, down from $805,126 in the same quarter of 2019. For the nine-month period, revenues decreased by 13% to $2,258,822, primarily due to the impact of COVID-19 on customer operations and reduced medical procedures. Despite these challenges, manufacturing revenues grew by 10%. ADMT continues investing in research and development for proprietary medical technologies, seeking future growth opportunities.
FAQ
What is the current stock price of ADM TRONICS UNLTD (ADMT)?
What is the market cap of ADM TRONICS UNLTD (ADMT)?
What services does ADMT provide?
What is the Vet-Sonotron®?
How has ADMT performed financially?
What are ADMT’s areas of activity?
Where is ADMT headquartered?
What recent projects has ADMT undertaken?
What makes ADMT unique in the medical device industry?
What is ADMT's approach to research and development?
Who can benefit from ADMT’s services?
How can I get more information about ADMT?
